Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study-Reference-Cited by-同舟云学术

Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study

Published:2016-09-09 Issue:11 Volume:101 Page:1390-1397
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Garderet Laurent,Beohou Eric,Caillot Denis,Stoppa Anne Marie,Touzeau Cyrille,Chretien Marie Lorraine,Karlin Lionel,Moreau Philippe,Fontan Jean,Blaise Didier,Polge Emmanuelle,Gueye Mor Seny,Ikhlef Souhila,Marjanovic Zora,Labopin Myriam,Mohty Mohamad

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of melphalan 140 mg/m² followed by autologous stem cell transplantation in multiple myeloma patients with co‐morbidities: Single‐centre experience;eJHaem;2024-08-19

2. Risk factors of early disease progression and decreased survival for multiple myeloma patients after upfront autologous stem cell transplantation;Annals of Hematology;2024-03-13

3. The Impact of Renal Impairment in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation With Melphalan Conditioning;Journal of Hematology;2023-10

4. The First 100-day Outcomes of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients: Melphalan 200 mg/m² versus 140 mg/m² Conditioning Regimen;Turkish Journal of Clinics and Laboratory;2023-09-30

5. Autologous stem cell transplantation in patients older than 65 years with multiple myeloma: a real-world study;Hematology, Transfusion and Cell Therapy;2023-09